Debevoise Advises Blackstone as Lead Investor in DNAnexus’ Latest, $200 Million Financing Round

9 March 2022

Debevoise & Plimpton LLP is advising Blackstone Growth as lead investor in DNAnexus, Inc.’s latest $200 million financing round. The financing round is to accelerate the global adoption of DNAnexus’ technology, translating the world’s complex multi-omics and clinical data into tangible insights and personalized treatments. For more information, please see the company’s press release.

DNAnexus is a bioinformatics company that facilitates secure access and utilization of biomedical data while supporting collaboration across internal and external teams.

The Debevoise team is led by M&A partner Spencer Gilbert and includes partner Kevin Rinker, counsel Kim Le, associates Hannah Levine and Tiancheng (TC) Huang and law clerks Jarrett Lewis and Dillon Roach, benefits counsel Kathleen Emberger and law clerk Christopher Johnson, capital markets associate Benjamin Pedersen and law clerk Austin Poon, intellectual property associate Tigist Kassahun, antitrust partner Timothy McIver, counsel Kyra Bromley and associates William Dolan and Megan MacDonald, FDA regulatory partner Paul Rubin and associate Melissa Runsten, regulatory counsel Erich Grosz and litigation associate Fanny Gauthier.